Profile data is unavailable for this security.
About the company
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. It provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. It provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide. It also offers IRRAflow active fluid-exchange system.
- Revenue in USD (TTM)34.33m
- Net income in USD-23.14m
- Incorporated1998
- Employees115.00
- LocationClearpoint Neuro Inc120 S. SIERRA AVENUE, SUITE 100SOLANA BEACH 92075United StatesUSA
- Phone+1 (949) 900-6833
- Fax+1 (949) 900-6834
- Websitehttps://www.clearpointneuro.com/
More ▼
Mergers & acquisitions
| Acquired company | CLPT:NAQ since announced | Transaction value |
|---|---|---|
| Irras Holdings Inc | -21.26% | 5.00m |
Data delayed at least 15 minutes, as of Feb 11 2026 21:00 GMT.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Evolent Health Inc | 2.05bn | -180.89m | 304.67m | 4.50k | -- | 0.3617 | -- | 0.1483 | -1.57 | -1.57 | 17.85 | 7.55 | 0.829 | -- | 5.17 | 456,456.00 | -5.17 | -5.93 | -6.41 | -8.00 | 18.42 | 21.07 | -6.24 | -7.16 | -- | 0.189 | 0.5572 | -- | 30.09 | 30.04 | 34.31 | -- | -6.87 | -- |
| Sight Sciences Inc | 76.05m | -46.11m | 305.07m | 216.00 | -- | 4.71 | -- | 4.01 | -0.8955 | -0.8955 | 1.47 | 1.23 | 0.5854 | 1.42 | 6.71 | 352,092.60 | -35.49 | -35.50 | -39.37 | -38.53 | 86.83 | 82.63 | -60.63 | -94.20 | 8.93 | -76.38 | 0.384 | -- | -1.47 | 27.89 | 7.27 | -- | -10.54 | -- |
| Carlsmed Inc | -100.00bn | -100.00bn | 320.18m | 100.00 | -- | 3.00 | -- | -- | -- | -- | -- | 4.01 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 11.91 | -- | 0.1265 | -- | 97.16 | -- | -31.49 | -- | -- | -- |
| Owlet Inc | 99.64m | -42.45m | 322.42m | 80.00 | -- | -- | -- | 3.24 | -2.75 | -2.75 | 6.08 | -2.34 | 1.52 | 3.80 | 4.36 | 1,245,500.00 | -60.37 | -64.44 | -244.32 | -331.11 | 52.06 | 44.29 | -39.68 | -58.72 | 0.9074 | -2.48 | -- | -- | 44.52 | 9.40 | 54.08 | -- | -17.23 | -- |
| Rxsight Inc | 142.09m | -35.73m | 337.57m | 498.00 | -- | 1.22 | -- | 2.38 | -0.8782 | -0.8782 | 3.50 | 6.72 | 0.4591 | 1.40 | 5.74 | 285,313.30 | -11.54 | -19.50 | -12.45 | -21.50 | 74.98 | 57.17 | -25.15 | -52.00 | 11.44 | -- | 0.0004 | -- | 57.09 | 128.61 | 43.52 | -- | 5.89 | -- |
| Senseonics Holdings Inc | 29.30m | -63.77m | 338.31m | 117.00 | -- | 4.32 | -- | 11.55 | -1.65 | -1.65 | 0.7565 | 1.92 | 0.248 | 3.62 | 5.22 | 250,410.30 | -53.98 | -71.11 | -70.98 | -94.75 | 41.11 | -14.81 | -217.65 | -594.09 | 5.93 | -29.18 | 0.3109 | -- | 0.3662 | 1.08 | -30.18 | -- | 16.46 | -- |
| Delcath Systems Inc | 79.60m | 1.20m | 356.67m | 96.00 | 1,160.92 | 3.11 | 255.86 | 4.48 | 0.0087 | 0.0087 | 2.10 | 3.25 | 1.02 | 1.26 | 7.70 | 829,197.90 | 1.54 | -94.54 | 1.90 | -143.97 | 86.29 | 81.31 | 1.50 | -339.85 | 13.71 | -- | 0.00 | -- | 1,701.70 | 88.10 | 44.66 | -- | 87.69 | -- |
| Clearpoint Neuro Inc | 34.33m | -23.14m | 404.28m | 115.00 | -- | 24.34 | -- | 11.78 | -0.8264 | -0.8264 | 1.23 | 0.5584 | 0.6829 | 1.95 | 7.52 | 298,539.10 | -46.03 | -35.94 | -54.48 | -41.48 | 61.31 | 63.49 | -67.40 | -74.87 | 5.56 | -92.37 | 0.6479 | -- | 31.04 | 22.85 | 14.37 | -- | 11.41 | -- |
| Orthopediatrics Corp | 227.41m | -45.61m | 428.32m | 562.00 | -- | 1.23 | -- | 1.88 | -1.96 | -1.96 | 9.74 | 13.93 | 0.4628 | 0.5149 | 4.83 | 404,644.10 | -9.28 | -5.87 | -9.97 | -6.44 | 71.73 | 74.27 | -20.06 | -16.55 | 3.52 | -5.96 | 0.2214 | -- | 37.65 | 23.06 | -80.33 | -- | 4.29 | -- |
| Cerus Corp | 225.97m | -15.96m | 428.36m | 281.00 | -- | 6.97 | -- | 1.90 | -0.0848 | -0.0848 | 1.20 | 0.3201 | 1.12 | 1.99 | 8.35 | 804,163.70 | -7.91 | -20.38 | -12.30 | -31.96 | 60.50 | 61.15 | -7.09 | -25.37 | 1.29 | -1.04 | 0.5772 | -- | 7.78 | 16.51 | 44.20 | -- | -20.50 | -- |
| AngioDynamics, Inc. | 307.31m | -27.71m | 454.22m | 675.00 | -- | 2.60 | -- | 1.48 | -0.6731 | -0.6731 | 7.47 | 4.24 | 1.10 | 2.12 | 7.02 | 455,268.20 | -9.87 | -13.69 | -13.83 | -16.19 | 54.58 | 52.46 | -9.02 | -21.32 | 1.33 | -- | 0.0329 | -- | -3.76 | 2.06 | 81.56 | -- | -10.06 | -- |
| Myriad Genetics Inc | 825.30m | -400.50m | 473.53m | 2.70k | -- | 1.27 | -- | 0.5738 | -4.34 | -4.34 | 8.97 | 4.00 | 0.9122 | 8.46 | 6.77 | 305,666.70 | -44.27 | -- | -53.15 | -- | 70.36 | -- | -48.53 | -- | 2.12 | -14.93 | 0.2427 | -- | 11.21 | -- | 51.65 | -- | -- | -- |
| Standard Biotools Inc | 128.83m | -109.46m | 476.86m | 818.00 | -- | 1.19 | -- | 3.70 | -0.289 | -0.3383 | 0.3399 | 1.04 | 0.211 | 1.97 | 5.27 | 157,490.20 | -17.93 | -29.45 | -22.06 | -35.68 | 47.94 | 50.11 | -84.97 | -79.68 | 4.14 | -- | 0.0008 | -- | 64.03 | 8.27 | -147.67 | -- | 26.98 | -- |
Data as of Feb 11 2026. Currency figures normalised to Clearpoint Neuro Inc's reporting currency: US Dollar USD
20.63%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Sep 2025 | 1.63m | 5.47% |
| The Vanguard Group, Inc.as of 31 Dec 2025 | 1.56m | 5.26% |
| Geode Capital Management LLCas of 30 Sep 2025 | 656.40k | 2.21% |
| SSgA Funds Management, Inc.as of 30 Sep 2025 | 482.65k | 1.62% |
| UBS Securities LLCas of 31 Dec 2025 | 338.84k | 1.14% |
| Brown Advisory LLCas of 30 Sep 2025 | 330.73k | 1.11% |
| Lane Generational LLCas of 30 Sep 2025 | 311.89k | 1.05% |
| Two Sigma Investments LPas of 30 Sep 2025 | 310.53k | 1.04% |
| Boone Capital Management LLCas of 30 Sep 2025 | 283.91k | 0.95% |
| Essex Investment Management Co. LLCas of 30 Sep 2025 | 232.46k | 0.78% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
